World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00011208
Date of registration: 08/05/2017
Prospective Registration: Yes
Primary sponsor: Saarland University
Public title: UMBRELLA Protocol SIOP-RTSG 2016 - Integrated research and guidelines for standardized diagnostics and therapy of kidney tumours in children, adolescents and young adults
Scientific title: UMBRELLA Protocol SIOP-RTSG 2016 - Integrated research and guidelines for standardized diagnostics and therapy of kidney tumours in children, adolescents and young adults - UMBRELLA
Date of first enrolment: 01/03/2019
Target sample size: 4000
Recruitment status: Recruiting
URL:  http://drks.de/search/en/trial/DRKS00011208
Study type:  observational
Study design:  Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: diagnostic  
Phase: 
Countries of recruitment
Argentina Australia Austria Belgium Bosnia & Herzegovina Brazil Chile China
Czechia Denmark Egypt Estonia Finland France Germany Greece
Hungary Italy Japan Jordan Latvia Lithuania Netherlands Norway
Poland Portugal Russia Serbia Singapore Slovakia Slovenia Spain
Sweden Switzerland United Kingdom
Contacts
Name: Norbert    Graf
Address:  Campus Homburg, Gebäude 9 66421 Homburg Germany
Telephone: 06841 1624711
Email: graf@uks.eu
Affiliation:  Klinik für Pädiatrische Onkologie und HämatologieUniversitätsklinikum Homburg
Name: Norbert    Graf
Address:  Campus Homburg, Gebäude 9 66421 Homburg Germany
Telephone: 06841 1624711
Email: graf@uks.eu
Affiliation:  Klinik für Pädiatrische Onkologie und HämatologieUniversitätsklinikum Homburg
Key inclusion & exclusion criteria
Inclusion criteria: All children with a kidney Tumor and adults with nephroblastom if they are diagnosed in a participating centre. Participating centres have to register all such pateints into the UMBRELLA SIOP-RTSG 2016 protocol
Exclusion criteria: Missing informed consent is the only exclusion criterion.

Age minimum: None
Age maximum: None
Gender: All
Health Condition(s) or Problem(s) studied
Malignant neoplasm of kidney, except renal pelvis

C64
Intervention(s)
Group 1: Treatment of the different kidney tumours is not a subject of the study. This is done according to SIOP 2001 (DRKS-ID of the study: DRKS00003769). The aim is to standardize diagnosis and and treatment in participating countries.
Primary Outcome(s)
Characterization of new biomarkers for diagnosis, prognosis and treatment
Secondary Outcome(s)
Standardization of diagnosis and treatment
Secondary ID(s)
U1111-1196-3034
Source(s) of Monetary Support
Elterninitiative krebskranke Kinder im Saarland e.V.
Secondary Sponsor(s)
Deutsche Kinderkrebsstiftung
Ethics review
Status: Approved
Approval date: 21/12/2016
Contact:
ethikkommission@aeksaar.de
Ethikkommission bei der Ärztekammer des Saarlandes
+49-681-4003216
ethikkommission@aeksaar.de
Results
Results available:
Date Posted:
Date Completed:
URL: http://drks.de/search/en/trial/DRKS00011208#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history